nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GSK3B—epithelium—primary biliary cirrhosis	0.0272	0.171	CbGeAlD
Lithium—Salivary gland enlargement—Ursodeoxycholic acid—primary biliary cirrhosis	0.0263	0.0691	CcSEcCtD
Lithium—Salivary gland enlargement—Chenodeoxycholic acid—primary biliary cirrhosis	0.0263	0.0691	CcSEcCtD
Lithium—GSK3B—smooth muscle tissue—primary biliary cirrhosis	0.0262	0.164	CbGeAlD
Lithium—GSK3A—smooth muscle tissue—primary biliary cirrhosis	0.0228	0.143	CbGeAlD
Lithium—IMPA1—liver—primary biliary cirrhosis	0.0209	0.131	CbGeAlD
Lithium—GRIA3—liver—primary biliary cirrhosis	0.0178	0.112	CbGeAlD
Lithium—IMPA2—liver—primary biliary cirrhosis	0.0157	0.0985	CbGeAlD
Lithium—GSK3B—liver—primary biliary cirrhosis	0.0154	0.0967	CbGeAlD
Lithium—GSK3A—liver—primary biliary cirrhosis	0.0134	0.084	CbGeAlD
Lithium—Hypothyroidism—Colchicine—primary biliary cirrhosis	0.0127	0.0333	CcSEcCtD
Lithium—Psoriasis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0116	0.0305	CcSEcCtD
Lithium—Psoriasis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0116	0.0305	CcSEcCtD
Lithium—Skin ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.00939	0.0246	CcSEcCtD
Lithium—Skin ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.00939	0.0246	CcSEcCtD
Lithium—Oliguria—Colchicine—primary biliary cirrhosis	0.00883	0.0232	CcSEcCtD
Lithium—Urinary incontinence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00706	0.0185	CcSEcCtD
Lithium—Urinary incontinence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00706	0.0185	CcSEcCtD
Lithium—Dehydration—Colchicine—primary biliary cirrhosis	0.00549	0.0144	CcSEcCtD
Lithium—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00521	0.0137	CcSEcCtD
Lithium—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00494	0.0129	CcSEcCtD
Lithium—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00494	0.0129	CcSEcCtD
Lithium—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0047	0.0123	CcSEcCtD
Lithium—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0047	0.0123	CcSEcCtD
Lithium—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00417	0.011	CcSEcCtD
Lithium—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00417	0.011	CcSEcCtD
Lithium—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00415	0.0109	CcSEcCtD
Lithium—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00415	0.0109	CcSEcCtD
Lithium—Alopecia—Colchicine—primary biliary cirrhosis	0.00361	0.00947	CcSEcCtD
Lithium—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00342	0.00898	CcSEcCtD
Lithium—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00342	0.00898	CcSEcCtD
Lithium—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00328	0.0086	CcSEcCtD
Lithium—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00328	0.0086	CcSEcCtD
Lithium—Angioedema—Colchicine—primary biliary cirrhosis	0.00325	0.00853	CcSEcCtD
Lithium—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00324	0.00851	CcSEcCtD
Lithium—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00324	0.00851	CcSEcCtD
Lithium—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00315	0.00826	CcSEcCtD
Lithium—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00315	0.00826	CcSEcCtD
Lithium—Arthralgia—Colchicine—primary biliary cirrhosis	0.00303	0.00795	CcSEcCtD
Lithium—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00292	0.00766	CcSEcCtD
Lithium—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00292	0.00766	CcSEcCtD
Lithium—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00753	CcSEcCtD
Lithium—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00753	CcSEcCtD
Lithium—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00752	CcSEcCtD
Lithium—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00752	CcSEcCtD
Lithium—Shock—Colchicine—primary biliary cirrhosis	0.00286	0.00749	CcSEcCtD
Lithium—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00281	0.00737	CcSEcCtD
Lithium—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00281	0.00737	CcSEcCtD
Lithium—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00726	CcSEcCtD
Lithium—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00726	CcSEcCtD
Lithium—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00714	CcSEcCtD
Lithium—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00714	CcSEcCtD
Lithium—Hypotension—Colchicine—primary biliary cirrhosis	0.00271	0.00712	CcSEcCtD
Lithium—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00269	0.00705	CcSEcCtD
Lithium—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00269	0.00705	CcSEcCtD
Lithium—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00266	0.00698	CcSEcCtD
Lithium—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00266	0.00698	CcSEcCtD
Lithium—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00264	0.00694	CcSEcCtD
Lithium—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00263	0.0069	CcSEcCtD
Lithium—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00263	0.0069	CcSEcCtD
Lithium—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00261	0.00684	CcSEcCtD
Lithium—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00261	0.00684	CcSEcCtD
Lithium—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00673	CcSEcCtD
Lithium—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00673	CcSEcCtD
Lithium—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00252	0.00662	CcSEcCtD
Lithium—Fatigue—Colchicine—primary biliary cirrhosis	0.0025	0.00657	CcSEcCtD
Lithium—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00249	0.00652	CcSEcCtD
Lithium—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00249	0.00652	CcSEcCtD
Lithium—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00244	0.00639	CcSEcCtD
Lithium—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00244	0.00639	CcSEcCtD
Lithium—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00238	0.00623	CcSEcCtD
Lithium—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00238	0.00623	CcSEcCtD
Lithium—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00237	0.00623	CcSEcCtD
Lithium—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00608	CcSEcCtD
Lithium—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00608	CcSEcCtD
Lithium—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0023	0.00602	CcSEcCtD
Lithium—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0023	0.00602	CcSEcCtD
Lithium—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00229	0.00602	CcSEcCtD
Lithium—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00595	CcSEcCtD
Lithium—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00595	CcSEcCtD
Lithium—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00225	0.0059	CcSEcCtD
Lithium—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00225	0.0059	CcSEcCtD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL4—primary biliary cirrhosis	0.00216	0.00471	CbGpPWpGaD
Lithium—GSK3A—Constitutive PI3K/AKT Signaling in Cancer—CD80—primary biliary cirrhosis	0.00215	0.00469	CbGpPWpGaD
Lithium—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00215	0.00564	CcSEcCtD
Lithium—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00215	0.00564	CcSEcCtD
Lithium—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00213	0.0056	CcSEcCtD
Lithium—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00213	0.0056	CcSEcCtD
Lithium—Asthenia—Colchicine—primary biliary cirrhosis	0.00208	0.00546	CcSEcCtD
Lithium—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00541	CcSEcCtD
Lithium—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00541	CcSEcCtD
Lithium—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00541	CcSEcCtD
Lithium—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00541	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.002	0.00434	CbGpPWpGaD
Lithium—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00199	0.00521	CcSEcCtD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—TAB1—primary biliary cirrhosis	0.00196	0.00426	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—RPS6KA4—primary biliary cirrhosis	0.00195	0.00425	CbGpPWpGaD
Lithium—GSK3A—PI-3K cascade—CD80—primary biliary cirrhosis	0.00194	0.00422	CbGpPWpGaD
Lithium—GSK3A—PI3K/AKT activation—CD80—primary biliary cirrhosis	0.00189	0.00412	CbGpPWpGaD
Lithium—GSK3A—GAB1 signalosome—CD80—primary biliary cirrhosis	0.00188	0.00409	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—MMP9—primary biliary cirrhosis	0.00188	0.00409	CbGpPWpGaD
Lithium—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00491	CcSEcCtD
Lithium—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00491	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—ICAM3—primary biliary cirrhosis	0.00186	0.00404	CbGpPWpGaD
Lithium—GSK3B—Hair Follicle Development: Induction (Part 1 of 3)—NFKB1—primary biliary cirrhosis	0.00186	0.00404	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—NFKB1—primary biliary cirrhosis	0.00186	0.00404	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—CD79A—primary biliary cirrhosis	0.00185	0.00402	CbGpPWpGaD
Lithium—Vomiting—Colchicine—primary biliary cirrhosis	0.00185	0.00484	CcSEcCtD
Lithium—GSK3A—Role of LAT2/NTAL/LAB on calcium mobilization—CD80—primary biliary cirrhosis	0.00184	0.004	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—AGT—primary biliary cirrhosis	0.00183	0.00399	CbGpPWpGaD
Lithium—Rash—Colchicine—primary biliary cirrhosis	0.00183	0.0048	CcSEcCtD
Lithium—Dermatitis—Colchicine—primary biliary cirrhosis	0.00183	0.0048	CcSEcCtD
Lithium—Headache—Colchicine—primary biliary cirrhosis	0.00182	0.00477	CcSEcCtD
Lithium—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00468	CcSEcCtD
Lithium—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00468	CcSEcCtD
Lithium—GSK3B—LPA receptor mediated events—MMP2—primary biliary cirrhosis	0.00178	0.00388	CbGpPWpGaD
Lithium—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00172	0.00453	CcSEcCtD
Lithium—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00172	0.00453	CcSEcCtD
Lithium—Nausea—Colchicine—primary biliary cirrhosis	0.00172	0.00452	CcSEcCtD
Lithium—GSK3A—Insulin Signaling—RPS6KB1—primary biliary cirrhosis	0.00171	0.00373	CbGpPWpGaD
Lithium—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00435	CcSEcCtD
Lithium—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00435	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—CD3D—primary biliary cirrhosis	0.00166	0.00361	CbGpPWpGaD
Lithium—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00431	CcSEcCtD
Lithium—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00431	CcSEcCtD
Lithium—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00431	CcSEcCtD
Lithium—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00431	CcSEcCtD
Lithium—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00429	CcSEcCtD
Lithium—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00429	CcSEcCtD
Lithium—GSK3B—Focal Adhesion—COL1A1—primary biliary cirrhosis	0.00163	0.00355	CbGpPWpGaD
Lithium—GSK3B—Constitutive PI3K/AKT Signaling in Cancer—CD80—primary biliary cirrhosis	0.00159	0.00346	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—NFKB1—primary biliary cirrhosis	0.00158	0.00344	CbGpPWpGaD
Lithium—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00406	CcSEcCtD
Lithium—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00406	CcSEcCtD
Lithium—GSK3A—Metabolism of proteins—ACE2—primary biliary cirrhosis	0.00155	0.00336	CbGpPWpGaD
Lithium—GSK3A—Immune System—ICAM3—primary biliary cirrhosis	0.00153	0.00332	CbGpPWpGaD
Lithium—IMPA2—Metabolism—NUP210—primary biliary cirrhosis	0.00151	0.00328	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—NFKB1—primary biliary cirrhosis	0.0015	0.00326	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—CD80—primary biliary cirrhosis	0.00145	0.00316	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—TAB1—primary biliary cirrhosis	0.00145	0.00315	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—MAP3K14—primary biliary cirrhosis	0.00144	0.00314	CbGpPWpGaD
Lithium—GSK3B—PI-3K cascade—CD80—primary biliary cirrhosis	0.00143	0.00312	CbGpPWpGaD
Lithium—GSK3B—PI3K/AKT activation—CD80—primary biliary cirrhosis	0.0014	0.00305	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ABCG2—primary biliary cirrhosis	0.0014	0.00305	CbGpPWpGaD
Lithium—GSK3B—GAB1 signalosome—CD80—primary biliary cirrhosis	0.00139	0.00302	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—CD80—primary biliary cirrhosis	0.00139	0.00302	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—RPS6KB1—primary biliary cirrhosis	0.00138	0.003	CbGpPWpGaD
Lithium—GSK3B—Notch Signaling Pathway—NFKB1—primary biliary cirrhosis	0.00138	0.003	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—CD80—primary biliary cirrhosis	0.00137	0.00297	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—CD79A—primary biliary cirrhosis	0.00136	0.00297	CbGpPWpGaD
Lithium—GSK3A—Immune System—SP100—primary biliary cirrhosis	0.00136	0.00296	CbGpPWpGaD
Lithium—GSK3B—Role of LAT2/NTAL/LAB on calcium mobilization—CD80—primary biliary cirrhosis	0.00136	0.00295	CbGpPWpGaD
Lithium—IMPA1—Metabolism—NUP210—primary biliary cirrhosis	0.00134	0.00292	CbGpPWpGaD
Lithium—GSK3B—LPA receptor mediated events—MMP9—primary biliary cirrhosis	0.00134	0.00292	CbGpPWpGaD
Lithium—GSK3B—LPA receptor mediated events—NFKB1—primary biliary cirrhosis	0.00133	0.00289	CbGpPWpGaD
Lithium—GRIA3—BDNF signaling pathway—NFKB1—primary biliary cirrhosis	0.00131	0.00285	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—ELMO1—primary biliary cirrhosis	0.00131	0.00285	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—CD80—primary biliary cirrhosis	0.0013	0.00284	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—CD80—primary biliary cirrhosis	0.0013	0.00283	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—CD80—primary biliary cirrhosis	0.00129	0.00281	CbGpPWpGaD
Lithium—GSK3A—B Cell Receptor Signaling Pathway—NFKB1—primary biliary cirrhosis	0.00129	0.0028	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—CD80—primary biliary cirrhosis	0.00129	0.0028	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—CD80—primary biliary cirrhosis	0.00127	0.00276	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—RPS6KB1—primary biliary cirrhosis	0.00127	0.00276	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ABCG2—primary biliary cirrhosis	0.00125	0.00271	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD3D—primary biliary cirrhosis	0.00123	0.00267	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—TYK2—primary biliary cirrhosis	0.00122	0.00267	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—CD80—primary biliary cirrhosis	0.00121	0.00263	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—CD80—primary biliary cirrhosis	0.00121	0.00263	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—CD80—primary biliary cirrhosis	0.00121	0.00263	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CTGF—primary biliary cirrhosis	0.0012	0.00261	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—CD80—primary biliary cirrhosis	0.0012	0.00261	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GOT2—primary biliary cirrhosis	0.00119	0.00259	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—CD80—primary biliary cirrhosis	0.00119	0.00259	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—CD80—primary biliary cirrhosis	0.00118	0.00257	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—TYK2—primary biliary cirrhosis	0.00117	0.00255	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—REN—primary biliary cirrhosis	0.00117	0.00255	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.00117	0.00255	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—NFKB1—primary biliary cirrhosis	0.00117	0.00254	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—TYK2—primary biliary cirrhosis	0.00115	0.00251	CbGpPWpGaD
Lithium—GSK3B—Immune System—ICAM3—primary biliary cirrhosis	0.00113	0.00245	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—CD80—primary biliary cirrhosis	0.00112	0.00244	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—TYK2—primary biliary cirrhosis	0.0011	0.0024	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—TYK2—primary biliary cirrhosis	0.0011	0.00238	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—TYK2—primary biliary cirrhosis	0.00109	0.00237	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—NFKB1—primary biliary cirrhosis	0.00109	0.00237	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—TYK2—primary biliary cirrhosis	0.00109	0.00236	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—CD80—primary biliary cirrhosis	0.00107	0.00233	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—CD80—primary biliary cirrhosis	0.00107	0.00233	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CTGF—primary biliary cirrhosis	0.00107	0.00233	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—MAP3K14—primary biliary cirrhosis	0.00107	0.00232	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—primary biliary cirrhosis	0.00107	0.00232	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GOT2—primary biliary cirrhosis	0.00106	0.00231	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GGT1—primary biliary cirrhosis	0.00103	0.00224	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GOT1—primary biliary cirrhosis	0.00103	0.00224	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—CD80—primary biliary cirrhosis	0.00103	0.00223	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—IGFBP1—primary biliary cirrhosis	0.00102	0.00222	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—TYK2—primary biliary cirrhosis	0.00102	0.00222	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—TYK2—primary biliary cirrhosis	0.00102	0.00222	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—TYK2—primary biliary cirrhosis	0.00102	0.00222	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—TYK2—primary biliary cirrhosis	0.00101	0.0022	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—CD80—primary biliary cirrhosis	0.00101	0.0022	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD3D—primary biliary cirrhosis	0.00101	0.00219	CbGpPWpGaD
Lithium—GSK3B—Immune System—SP100—primary biliary cirrhosis	0.001	0.00219	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—TYK2—primary biliary cirrhosis	0.001	0.00218	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—TYK2—primary biliary cirrhosis	0.000999	0.00217	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—NFKB1—primary biliary cirrhosis	0.000992	0.00216	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—ELMO1—primary biliary cirrhosis	0.000967	0.0021	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—MMP9—primary biliary cirrhosis	0.000965	0.0021	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—CD80—primary biliary cirrhosis	0.000964	0.0021	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—CD80—primary biliary cirrhosis	0.000959	0.00209	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—CD80—primary biliary cirrhosis	0.000955	0.00208	CbGpPWpGaD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000951	0.00207	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—CD80—primary biliary cirrhosis	0.00095	0.00207	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—CD80—primary biliary cirrhosis	0.000936	0.00204	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL7R—primary biliary cirrhosis	0.000924	0.00201	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—NFKB1—primary biliary cirrhosis	0.000921	0.002	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GGT1—primary biliary cirrhosis	0.000916	0.00199	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GOT1—primary biliary cirrhosis	0.000916	0.00199	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PPARGC1A—primary biliary cirrhosis	0.000914	0.00199	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—TYK2—primary biliary cirrhosis	0.000905	0.00197	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—TYK2—primary biliary cirrhosis	0.000904	0.00197	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000903	0.00197	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—CD80—primary biliary cirrhosis	0.000894	0.00194	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—CD80—primary biliary cirrhosis	0.000894	0.00194	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—CD80—primary biliary cirrhosis	0.000894	0.00194	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—CD80—primary biliary cirrhosis	0.000886	0.00193	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—CD80—primary biliary cirrhosis	0.000878	0.00191	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAP3K14—primary biliary cirrhosis	0.000876	0.00191	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—CD80—primary biliary cirrhosis	0.000874	0.0019	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—NFKB1—primary biliary cirrhosis	0.000866	0.00189	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—TYK2—primary biliary cirrhosis	0.000866	0.00188	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—TYK2—primary biliary cirrhosis	0.000852	0.00185	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—primary biliary cirrhosis	0.000833	0.00181	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000832	0.00181	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—CD80—primary biliary cirrhosis	0.000827	0.0018	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—CD80—primary biliary cirrhosis	0.000824	0.00179	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PPARGC1A—primary biliary cirrhosis	0.000815	0.00177	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—TYK2—primary biliary cirrhosis	0.000814	0.00177	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—TYK2—primary biliary cirrhosis	0.00081	0.00176	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—TYK2—primary biliary cirrhosis	0.000806	0.00175	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—TYK2—primary biliary cirrhosis	0.000802	0.00175	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	0.000796	0.00173	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—CD80—primary biliary cirrhosis	0.000792	0.00172	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CTLA4—primary biliary cirrhosis	0.00078	0.0017	CbGpPWpGaD
Lithium—GSK3A—Immune System—ELMO1—primary biliary cirrhosis	0.000762	0.00166	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TAB1—primary biliary cirrhosis	0.000761	0.00166	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—TYK2—primary biliary cirrhosis	0.000755	0.00164	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—TYK2—primary biliary cirrhosis	0.000755	0.00164	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—TYK2—primary biliary cirrhosis	0.000755	0.00164	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000749	0.00163	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—TYK2—primary biliary cirrhosis	0.000748	0.00163	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD79A—primary biliary cirrhosis	0.000744	0.00162	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD3D—primary biliary cirrhosis	0.000743	0.00162	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—TYK2—primary biliary cirrhosis	0.000741	0.00161	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—TYK2—primary biliary cirrhosis	0.000738	0.00161	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—NFKB1—primary biliary cirrhosis	0.000736	0.0016	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—HIF1A—primary biliary cirrhosis	0.000735	0.0016	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—ACE—primary biliary cirrhosis	0.000731	0.00159	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—MMP9—primary biliary cirrhosis	0.000713	0.00155	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AGT—primary biliary cirrhosis	0.000712	0.00155	CbGpPWpGaD
Lithium—GSK3A—Disease—ELMO1—primary biliary cirrhosis	0.000704	0.00153	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—TYK2—primary biliary cirrhosis	0.000696	0.00151	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—NFKB1—primary biliary cirrhosis	0.000693	0.00151	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL7R—primary biliary cirrhosis	0.000683	0.00149	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—TYK2—primary biliary cirrhosis	0.000668	0.00145	CbGpPWpGaD
Lithium—GSK3A—Immune System—NUP210—primary biliary cirrhosis	0.000653	0.00142	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAP3K14—primary biliary cirrhosis	0.000647	0.00141	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AGT—primary biliary cirrhosis	0.000635	0.00138	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—primary biliary cirrhosis	0.000616	0.00134	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000609	0.00133	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—CD80—primary biliary cirrhosis	0.000609	0.00132	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD40LG—primary biliary cirrhosis	0.000607	0.00132	CbGpPWpGaD
Lithium—GSK3A—Disease—NUP210—primary biliary cirrhosis	0.000603	0.00131	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	0.000588	0.00128	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000587	0.00128	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CTLA4—primary biliary cirrhosis	0.000576	0.00125	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—PPARGC1A—primary biliary cirrhosis	0.00057	0.00124	CbGpPWpGaD
Lithium—GSK3B—Immune System—ELMO1—primary biliary cirrhosis	0.000563	0.00123	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TAB1—primary biliary cirrhosis	0.000562	0.00122	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD79A—primary biliary cirrhosis	0.00055	0.0012	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ALB—primary biliary cirrhosis	0.000546	0.00119	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—NFKB1—primary biliary cirrhosis	0.000544	0.00118	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—NFKB1—primary biliary cirrhosis	0.000542	0.00118	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000533	0.00116	CbGpPWpGaD
Lithium—GSK3B—Disease—ELMO1—primary biliary cirrhosis	0.00052	0.00113	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—TYK2—primary biliary cirrhosis	0.000514	0.00112	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000493	0.00107	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MMP2—primary biliary cirrhosis	0.000487	0.00106	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ALB—primary biliary cirrhosis	0.000487	0.00106	CbGpPWpGaD
Lithium—GSK3B—Immune System—NUP210—primary biliary cirrhosis	0.000483	0.00105	CbGpPWpGaD
Lithium—GSK3A—Disease—GOT2—primary biliary cirrhosis	0.000477	0.00104	CbGpPWpGaD
Lithium—GSK3A—Immune System—CTLA4—primary biliary cirrhosis	0.000473	0.00103	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD80—primary biliary cirrhosis	0.00047	0.00102	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—TYK2—primary biliary cirrhosis	0.000465	0.00101	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—AGT—primary biliary cirrhosis	0.000464	0.00101	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD79A—primary biliary cirrhosis	0.000451	0.000982	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD80—primary biliary cirrhosis	0.000451	0.000982	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CDH5—primary biliary cirrhosis	0.00045	0.00098	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD40LG—primary biliary cirrhosis	0.000448	0.000975	CbGpPWpGaD
Lithium—GSK3B—Disease—NUP210—primary biliary cirrhosis	0.000446	0.00097	CbGpPWpGaD
Lithium—GSK3A—Immune System—TAB1—primary biliary cirrhosis	0.000443	0.000964	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000433	0.000943	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—NFKB1—primary biliary cirrhosis	0.000427	0.000929	CbGpPWpGaD
Lithium—GSK3A—Disease—GOT1—primary biliary cirrhosis	0.000412	0.000896	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—NFKB1—primary biliary cirrhosis	0.0004	0.000871	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TYK2—primary biliary cirrhosis	0.000397	0.000863	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000394	0.000856	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD40LG—primary biliary cirrhosis	0.000368	0.000801	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MMP9—primary biliary cirrhosis	0.000366	0.000797	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000364	0.000792	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—MMP2—primary biliary cirrhosis	0.000363	0.00079	CbGpPWpGaD
Lithium—GSK3B—Disease—GOT2—primary biliary cirrhosis	0.000352	0.000767	CbGpPWpGaD
Lithium—GSK3B—Immune System—CTLA4—primary biliary cirrhosis	0.00035	0.000761	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MMP2—primary biliary cirrhosis	0.000348	0.000757	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD80—primary biliary cirrhosis	0.000347	0.000756	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD79A—primary biliary cirrhosis	0.000334	0.000726	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD80—primary biliary cirrhosis	0.000333	0.000726	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TYK2—primary biliary cirrhosis	0.000332	0.000722	CbGpPWpGaD
Lithium—GSK3B—Immune System—TAB1—primary biliary cirrhosis	0.000327	0.000712	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—NFKB1—primary biliary cirrhosis	0.000309	0.000673	CbGpPWpGaD
Lithium—GSK3B—Disease—GOT1—primary biliary cirrhosis	0.000304	0.000662	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—NFKB1—primary biliary cirrhosis	0.000297	0.000646	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TYK2—primary biliary cirrhosis	0.000293	0.000638	CbGpPWpGaD
Lithium—GSK3A—Disease—HIF1A—primary biliary cirrhosis	0.000286	0.000623	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000277	0.000604	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD80—primary biliary cirrhosis	0.000274	0.000596	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD40LG—primary biliary cirrhosis	0.000272	0.000592	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MMP9—primary biliary cirrhosis	0.000261	0.000569	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS2—primary biliary cirrhosis	0.00026	0.000567	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—NFKB1—primary biliary cirrhosis	0.000259	0.000563	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000253	0.000551	CbGpPWpGaD
Lithium—GSK3A—Disease—CD80—primary biliary cirrhosis	0.000253	0.00055	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000239	0.00052	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000231	0.000504	CbGpPWpGaD
Lithium—GSK3A—Immune System—TYK2—primary biliary cirrhosis	0.000231	0.000503	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—NFKB1—primary biliary cirrhosis	0.000228	0.000497	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—NFKB1—primary biliary cirrhosis	0.000219	0.000477	CbGpPWpGaD
Lithium—GSK3A—Disease—TYK2—primary biliary cirrhosis	0.000213	0.000464	CbGpPWpGaD
Lithium—GSK3B—Disease—HIF1A—primary biliary cirrhosis	0.000212	0.00046	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000205	0.000446	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD80—primary biliary cirrhosis	0.000202	0.00044	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000201	0.000436	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AGT—primary biliary cirrhosis	0.0002	0.000435	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS2—primary biliary cirrhosis	0.000192	0.000419	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000187	0.000407	CbGpPWpGaD
Lithium—GSK3B—Disease—CD80—primary biliary cirrhosis	0.000187	0.000406	CbGpPWpGaD
Lithium—GSK3A—Immune System—NFKB1—primary biliary cirrhosis	0.00018	0.000392	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CD80—primary biliary cirrhosis	0.000177	0.000385	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000176	0.000384	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000171	0.000372	CbGpPWpGaD
Lithium—GSK3B—Immune System—TYK2—primary biliary cirrhosis	0.000171	0.000372	CbGpPWpGaD
Lithium—GSK3B—Disease—TYK2—primary biliary cirrhosis	0.000158	0.000343	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TYK2—primary biliary cirrhosis	0.000149	0.000325	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000148	0.000322	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AGT—primary biliary cirrhosis	0.000148	0.000321	CbGpPWpGaD
Lithium—GSK3B—Immune System—NFKB1—primary biliary cirrhosis	0.000133	0.000289	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CD80—primary biliary cirrhosis	0.000131	0.000285	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP9—primary biliary cirrhosis	0.000118	0.000256	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NFKB1—primary biliary cirrhosis	0.000116	0.000253	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TYK2—primary biliary cirrhosis	0.00011	0.00024	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP9—primary biliary cirrhosis	8.69e-05	0.000189	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NFKB1—primary biliary cirrhosis	8.6e-05	0.000187	CbGpPWpGaD
